This issue of Dermatologic Clinics, guest edited by John E. Harris, MD, PhD, is devoted to Vitiligo. Articles in this timely issue include: History of Vitiligo Management; Quality of Life/Burden of Disease; Comorbidities/Systemic Effects; Skin Cancer Risk (NMSC/Melanoma); Presentations, Signs of Activity, Differential Diagnosis; Segmental Vitiligo; Chemical-Induced Vitiligo; Medical Therapy and Maintenance of Vitiligo; Phototherapy and Combination Therapies for Vitiligo; Surgical Therapy; Depigmentation Therapy; Special Considerations in Children with Vitiligo; Role of Diet and Supplements in Vitiligo Management; Genetics; Pathogenesis and Emerging Treatments; and Repigmentation/Melanocyte Regeneration in Vitiligo.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. The Medical Treatment of Vitiligo: An Historical Review - p. 107 9. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients - p. 117 10. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients - p. 129 11. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo - p. 135 12. Segmental Vitiligo - p. 145 13. Chemical-Induced Vitiligo - p. 151 14. Medical and Maintenance Treatments for Vitiligo - p. 163 15. Phototherapy and Combination Therapies for Vitiligo - p. 171 16. Surgical Therapies for Vitiligo - p. 193 17. Repigmentation through Melanocyte Regeneration in Vitiligo - p. 205 18. Depigmentation Therapies for Vitiligo - p. 219 19. Special Considerations in Children with Vitiligo - p. 229 20. The Role of Diet and Supplements in Vitiligo Management - p. 235 21. Genetics of Vitiligo - p. 245 22. Vitiligo Pathogenesis and Emerging Treatments - p. 257 23. Index - p. 267
This issue of Dermatologic Clinics, guest edited by John E. Harris, MD, PhD, is devoted to Vitiligo. Articles in this timely issue include: History of Vitiligo Management; Quality of Life/Burden of Disease; Comorbidities/Systemic Effects; Skin Cancer Risk (NMSC/Melanoma); Presentations, Signs of Activity, Differential Diagnosis; Segmental Vitiligo; Chemical-Induced Vitiligo; Medical Therapy and Maintenance of Vitiligo; Phototherapy and Combination Therapies for Vitiligo; Surgical Therapy; Depigmentation Therapy; Special Considerations in Children with Vitiligo; Role of Diet and Supplements in Vitiligo Management; Genetics; Pathogenesis and Emerging Treatments; and Repigmentation/Melanocyte Regeneration in Vitiligo.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. The Medical Treatment of Vitiligo: An Historical Review - p. 107 9. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients - p. 117 10. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients - p. 129 11. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo - p. 135 12. Segmental Vitiligo - p. 145 13. Chemical-Induced Vitiligo - p. 151 14. Medical and Maintenance Treatments for Vitiligo - p. 163 15. Phototherapy and Combination Therapies for Vitiligo - p. 171 16. Surgical Therapies for Vitiligo - p. 193 17. Repigmentation through Melanocyte Regeneration in Vitiligo - p. 205 18. Depigmentation Therapies for Vitiligo - p. 219 19. Special Considerations in Children with Vitiligo - p. 229 20. The Role of Diet and Supplements in Vitiligo Management - p. 235 21. Genetics of Vitiligo - p. 245 22. Vitiligo Pathogenesis and Emerging Treatments - p. 257 23. Index - p. 267
